Delivery Order SPE2DB22D1202-SPE2DB24FULV5
- Not listed
- This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,238.27 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of Otezla 30 mg tablets (60s) to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The $7,807.93 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The $43,466.61 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 15, 2023. AmerisourceBergen is the child company of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $14,955.31 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 20, 2022, with a completion date of May 23, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp is a...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $24,369.11, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
- This federal contract award is for the delivery of Otezla 30mg tablets to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $27,230.48 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 22, 2024, with a period of performance through October 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $14,505.92 for the supply of Otezla 30 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and has an ultimate completion date of February 25, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This contract award, valued at $32,404.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company. The award provides for the delivery of Otezla 30 mg tablets under a firm-fixed-price delivery order contract. The contract has an ultimate completion date of April 29, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $10,805.74 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 23, 2022, with a completion date of February 24, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (the parent company of AmerisourceBergen Drug Corp) and the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,363.89 firm-fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FULV5Delivery Order
This federal contract award is for the delivery of Otezla 30 mg tablets in quantities of 60 to the Defense Logistics Agency (DLA). The $35,497.88 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract has an ultimate completion date of January 4, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order appears to be one of many fulfilling that broader IDC. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.5k | 1/3/24 |